Earnings are in focus with Nvidia, Crowdstrike, and Marvell Technology reporting in the coming days.

Bloomberg’s Nathan Hager previews what to expect from these companies in the week ahead with Mandeep Singh, Global Head of Tech Research for Bloomberg Intelligence.

 

 

Earnings are in focus with Nvidia, Crowdstrike, and Marvell Technology reporting in the coming days. Bloomberg&rsquo;s Nathan Hager previews what to expect from these companies in the week ahead with Mandeep Singh, Global Head of Tech Research for Bloomberg Intelligence.
&nbsp;
&nbsp;

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Week Ahead: Nvidia, Crowdstrike, Marvell Technology 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b0bde476-31b3-4346-bdd2-b4ad01395bf8/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners of the week:

- Moderna (MRNA) saw it shares soar to a record 177%, adding around $44 billion in value on Wednesday after it announced a personalized vaccine it developed with Merck (MRK) reduced the recurrence of melanoma in a large, late-stage trial. The breakthrough raises expectations for treating the deadliest form of skin cancer and shows the promise of the embattled mRNA technology.

- Crowdstrike (CRWD) shares fell after Axios reported the company chief technology officer is departing to start an AI-cyber fund. Current CTO Elia Zaitsev's new venture firm is reportedly targeting a $170 million fund. 

- Estée Lauder (EL) shares soared after the beauty conglomerate ended a run of three straight declines in annual revenue, reinforcing that turnaround efforts are paying off. The shares closed 16% higher in New York on Wednesday, the biggest daily gain since 2011. The advance pared the stock’s year-do-date decline to 6%.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners of the week:
- Moderna (MRNA) saw it shares soar to a record 177%, adding around $44 billion in value on Wednesday after it announced a personalized vaccine it developed with Merck (MRK) reduced the recurrence of melanoma in a large, late-stage trial. The breakthrough raises expectations for treating the deadliest form of skin cancer and shows the promise of the embattled mRNA technology.
- Crowdstrike (CRWD) shares fell after Axios reported the company chief technology officer is departing to start an AI-cyber fund. Current CTO Elia Zaitsev's new venture firm is reportedly targeting a $170 million fund.&nbsp;
- Est&eacute;e Lauder (EL) shares soared after the beauty conglomerate ended a run of three straight declines in annual revenue, reinforcing that turnaround efforts are paying off. The shares closed 16% higher in New York on Wednesday, the biggest daily gain since 2011. The advance pared the stock&rsquo;s year-do-date decline to 6%.

Weekly Roundup: Moderna Skyrockets, Crowdstrike Sinks, Estée Lauder Jumps

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b33ee3d2-3d8a-472a-8433-b4ad0165b1a3/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers: 

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Sally Bakewell, Carol Massar and Tim Stenovec. 

- Moderna (MRNA) and Merck (MRK) shares continued to gain on investor enthusiasm over their new personalized cancer vaccine. Earlier in the week, Moderna jumped to its biggest intraday gain on record. 

- Boston Beer (SAM) shares dropped in trading on Friday, after the alcoholic beverage maker announced Chief Financial Officer Diego Reynoso will be leaving the company on Sept. 14 to accept a new opportunity. Citi views Reynoso’s exit as a “meaningful loss” to the Samuel Adams maker given his key role in the company’s margin recovery program.

- Ubiquiti (UI) shares fell the most since May after the wireless-network equipment provider posted fiscal fourth-quarter gross margin that shrank from the third quarter. The margin was hurt by higher costs of components and shipping.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:&nbsp;
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Sally Bakewell, Carol Massar and Tim Stenovec.&nbsp;
- Moderna (MRNA) and Merck (MRK) shares continued to gain on investor enthusiasm over their new personalized cancer vaccine. Earlier in the week, Moderna jumped to its biggest intraday gain on record.&nbsp;
- Boston Beer (SAM) shares dropped in trading on Friday, after the alcoholic beverage maker announced Chief Financial Officer Diego Reynoso will be leaving the company on Sept. 14 to accept a new opportunity. Citi views Reynoso&rsquo;s exit as a &ldquo;meaningful loss&rdquo; to the Samuel Adams maker given his key role in the company&rsquo;s margin recovery program.
- Ubiquiti (UI) shares fell the most since May after the wireless-network equipment provider posted fiscal fourth-quarter gross margin that shrank from the third quarter. The margin was hurt by higher costs of components and shipping.

Closing Bell: Moderna Rallies, Boston Beer Drops, Ubiquiti Slumps

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/045c1ddd-0fe0-4f42-935e-b4ad0162cebf/transcript

Today’s biggest winners and losers in the stock market. 

On this episode of Stock Movers: 
Mining and royalty stocks are rising on Friday as bullion extended gains after the US Treasury’s unexpected ramp-up in buybacks of long-dated government debt and copper’s rise amid a supply squeeze. Shares of Newmont Corp. (NEM) led the sector higher as spot gold prices rose as much as 5.2% on Friday, putting it on track for its third weekly gain. 
Shares of Ross Stores (ROST) gained by the most in three months in the Friday trade. That’s after the off-price retailer boosted its earnings per share forecast for the full year. The company said it saw strength throughout the second quarter, with comparable store sales growth supported by “both an increase in new customers and higher engagement from existing customers.” 
Shares of Merck (MRK) climbed gain as much as 3.7% to top Wednesday’s record high. Merck and partner Moderna (MRNA) reported mid-week that their personalized cancer vaccine combined with Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. Shares of Moderna moved higher after the stock’s worst ever daily slide on Thursday - one day after the drugmaker’s record 177% surge that stemmed from a clinical trial win.

Today&rsquo;s biggest winners and losers in the stock market.&nbsp;
On this episode of Stock Movers:&nbsp;
<ul>
<li>Mining and royalty stocks are rising on Friday as bullion extended gains after the US Treasury&rsquo;s unexpected ramp-up in buybacks of long-dated government debt and copper&rsquo;s rise amid a supply squeeze. Shares of Newmont Corp. (NEM) led the sector higher as spot gold prices rose as much as 5.2% on Friday, putting it on track for its third weekly gain.&nbsp;</li>
<li>Shares of Ross Stores (ROST) gained by the most in three months in the Friday trade. That&rsquo;s after the off-price retailer boosted its earnings per share forecast for the full year. The company said it saw strength throughout the second quarter, with comparable store sales growth supported by &ldquo;both an increase in new customers and higher engagement from existing customers.&rdquo;&nbsp;</li>
<li>Shares of Merck (MRK) climbed gain as much as 3.7% to top Wednesday&rsquo;s record high. Merck and partner Moderna (MRNA) reported mid-week that their personalized cancer vaccine combined with Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. Shares of Moderna moved higher after the stock&rsquo;s worst ever daily slide on Thursday - one day after the drugmaker&rsquo;s record 177% surge that stemmed from a clinical trial win.</li>
</ul>

Newmont Leads Mining Stocks, Ross Stores Gains, Merck Hits All-Time High

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/d7b6dd98-fe57-4c55-8ad5-b4ad0139d4d5/transcript

Week Ahead: Nvidia, Crowdstrike, Marvell Technology

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips